- ICH GCP
- Реестр клинических исследований ЕС
Последние исследования
EudraCT Number: 2004-001583-52 | Sponsor Protocol Number: Intu | Start Date: 2004-09-22 | ||||||
Sponsor Name: Lund University Hospital | ||||||||
Full Title: Balanced anestesia for intubation of newborn premature infants – a randomized intervention study Balanserad anestesi för intubation av nyfödda prematura barn – en randomiserad interventionsstudie | ||||||||
Medical condition: Respiratory insufficiency in prematrue infants requiring ventilatory assistance and therefore intubation. Premedication before intubation. | ||||||||
|
||||||||
Population Age: Preterm newborn infants, Newborns, Under 18 | Gender: Male, Female | |||||||
Trial protocol: SE (Completed) | ||||||||
Trial results: (No results available) |
EudraCT Number: 2005-000393-47 | Sponsor Protocol Number: SP000680 | Start Date: 2004-09-22 | |||||||||||
Sponsor Name: AZIENDA UNIVERSITARIA POLICLINICO UMBERTO I DI ROMA | |||||||||||||
Full Title: Effect of Cannabis Based Medicine Extract Sativex on brain function as assessed by fMRI and neurophysiologic evaluation in patients with Multiple Sclerosis a double blind, randomised, placebo-co... | |||||||||||||
Medical condition: Treatment of spasticity in patients with Multiple Sclerosis | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2004-002125-42 | Sponsor Protocol Number: CTH9507J | Start Date: 2004-09-22 | ||||||
Sponsor Name: AZIENDA SANITARIA OSPEDALIERA "S. GIOVANNI BATTISTA DI TORINO" | ||||||||
Full Title: EFFECT OF PROLONGED TREATMENT WITH TH9507 ON IGF-I LEVELS IN ADOLESCENTS WITH ISOLATED GH DEFICIENCY DUE TO HYPOTHALAMIC PATHOGENESIS | ||||||||
Medical condition: EVALUATION OF GROWTH HORMONE RELEASE | ||||||||
|
||||||||
Population Age: Adults | Gender: Male, Female | |||||||
Trial protocol: IT (Ongoing) | ||||||||
Trial results: (No results available) |
EudraCT Number: 2004-001967-24 | Sponsor Protocol Number: L 9259 | Start Date: 2004-09-22 | ||||||
Sponsor Name: Sanofi-Synthelabo Rt. | ||||||||
Full Title: Kiegészítő zolpidem kezelés friss antidepresszáns kezelés alatt álló disztimiás vagy depressziós betegek alvászavarának kezelésében | ||||||||
Medical condition: A depresszióban szenvedő betegek alvászavarára jellemzően megfigyelhető kóros alvásparaméterek lehetnek az elalvás nehezítettsége, töredezett, felszínes alvás gyakori felébredésekkel, az újra elalv... | ||||||||
|
||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||
Trial protocol: HU (Completed) | ||||||||
Trial results: View results |
EudraCT Number: 2004-001091-40 | Sponsor Protocol Number: 2-47-52030-722 | Start Date: 2004-09-22 | ||||||
Sponsor Name: Beaufour Ipsen Pharma | ||||||||
Full Title: A Phase III, Prospective, Multicentre, Randomised, Open, Parallel Group Comparison of Lanreotide Autogel (90 and 120mg) Administered by Deep Subcutaneous Injection Every Four Weeks, with Sandostati... | ||||||||
Medical condition: Treatment of clinical symptoms of carcinoid syndrome. | ||||||||
|
||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||
Trial protocol: FI (Completed) | ||||||||
Trial results: View results |
EudraCT Number: 2004-000755-41 | Sponsor Protocol Number: RA/PR/3301/010/03 | Start Date: 2004-09-22 | |||||||||||
Sponsor Name: Chiesi Farmaceurtici S.p.A | |||||||||||||
Full Title: A three-month, double-blind, double dummy, parallel group, controlled study comparing the efficacy and safety between 12 µg twice daily of Formoterol-HFA and 12 µg twice daily of Formoterol-DPI (Fo... | |||||||||||||
Medical condition: Children Persistent Asthma | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-005396-34 | Sponsor Protocol Number: RG_10-040 | Start Date: 2004-09-22 | |||||||||||
Sponsor Name: University of Birmingham | |||||||||||||
Full Title: Treatment Protocol for T-Cell and B-Precursor Cell Lymphoblastic Lymphoma of the European Inter-group Co-operation on Childhood Non-Hodgkin-Lymphoma (EICNHL) | |||||||||||||
Medical condition: lymphoblastic lymphoma | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Children, Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2004-000348-25 | Sponsor Protocol Number: D6160C00031 | Start Date: 2004-09-22 | |||||||||||
Sponsor Name: ASTRAZENECA | |||||||||||||
Full Title: GALLANT 8 - A 24-Week Randomized, Double-Blind, Parallel-Group, Multi-Centre, Placebo-Controlled Study to Evaluate the Efficacy, Safety and Tolerability of Tesaglitazar Therapy when Added to the Th... | |||||||||||||
Medical condition: To prevent vascular disease associated with insulin resistence. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2004-001033-41 | Sponsor Protocol Number: H6D-MC-LVFZ | Start Date: 2004-09-22 | |||||||||||
Sponsor Name: ELI LILLY | |||||||||||||
Full Title: A Randomized, Double-Blind, Parallel-Design, Placebo-Controlled Study to Evluate the Efficacy and Safety of Tadalafil (2.5 mg e 5 mg) administered once daily to men with diabetes mellitus and erect... | |||||||||||||
Medical condition: Therapy of erectile disfunction to subjects with diabetes mellitus and erectile disfunction with a 2.5 mg or 5 mg daily dosing. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2004-001551-11 | Sponsor Protocol Number: Iloprost | Start Date: 2004-09-22 | ||||||
Sponsor Name: Lund University Hospital | ||||||||
Full Title: Behandling av förhöjt pulmonellt arteriellt tryck med inhalerad iloprost | ||||||||
Medical condition: Nyfödda barn som är i behov av respiratorvård pga RDS, mekoniumaspiration eller primär lunghypertension | ||||||||
|
||||||||
Population Age: Preterm newborn infants, Newborns, Under 18 | Gender: Male, Female | |||||||
Trial protocol: SE (Ongoing) | ||||||||
Trial results: (No results available) |